養殖治療薬市場：製品別、流通チャネル別-2025-2030年の世界予測

養殖治療薬市場は、2023年に25億1,000万米ドルと評価され、2024年には27億4,000万米ドルに達すると予測され、CAGR 9.13％で成長し、2030年には46億4,000万米ドルに達すると予測されています。

養殖治療薬には、魚類、軟体動物、甲殻類などの水生生物の健康と生産量を向上させるように設計された一連の製品と治療が含まれます。これには、病気の予防、生産性の向上、養殖種の健康の確保を目的とした医薬品、ワクチン、プロバイオティクス、栄養補助食品が含まれます。養殖治療薬の必要性は、持続可能な水産物の生産に対する需要の高まりと、水産養殖環境における疾病管理の課題から生じています。アプリケーションは、養殖場、孵化場、水生動物保健センターなどの最終用途を含む、繁殖、飼育、収穫を含む養殖ライフサイクルの様々な段階にわたります。

市場の成長は、タンパク質が豊富な飼料に対する世界の需要の増加、養殖方法における技術の進歩、水生疾病の発生率の上昇といった要因に影響されています。野生漁業が生態系に与える影響に対する意識の高まりも、より持続可能な養殖方法への投資に拍車をかけています。主な機会は、魚の健康と生産性を最大化しながら環境への影響を最小化する、先進的なワクチンとバイオベースの治療ソリューションの開発にあります。効果的な養殖治療薬は、病気の発生に対応するだけでなく、成長率や飼料効率も高めるため、イノベーションを目指す企業にとって魅力的な手段となります。

しかし、この市場は規制のハードルや治療法の開発・展開の高コストなどの限界に直面しています。水生生態系は複雑であるため、意図しない副作用なしに治療薬を導入することは困難です。さらに、世界的に統一された規制基準がないことが、市場への参入と拡大を複雑にしています。遺伝子組み換え生物の調査、リアルタイムの健康モニタリングのような精密養殖ツール、統合管理システムの開発は、技術革新の有望分野です。市場はやや細分化されているため、学術機関、政府機関、業界の利害関係者との協力は、貴重な洞察を提供し、養殖治療薬の進歩を促進することができます。費用対効果が高く、持続可能でスケーラブルなソリューションのニーズに対応することは、このダイナミックな市場の成長を取り込む上で極めて重要です。

市場力学：急速に進化する養殖治療薬市場の主要市場インサイトを公開

養殖治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の養殖産業の成長
  • 養殖動物に影響を及ぼす細菌性疾患の増加
  • 養殖用薬剤に対する政府の有利な承認
• 市場抑制要因
  • 養殖治療薬における抗菌剤耐性の発生
• 市場機会
  • 養殖治療薬の進歩と、より効果的な養殖治療薬への需要の高まり
  • 養殖治療薬の研究開発を支援する政府の広範な取り組み
• 市場の課題
  • 養殖治療薬の副作用

ポーターのファイブフォース：養殖治療薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：養殖治療薬市場における外部からの影響の把握

外部マクロ環境要因は、養殖治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析養殖治療薬市場における競合情勢の把握

養殖治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス養殖治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、養殖治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨養殖治療薬市場における成功への道筋を描く

養殖治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で成長する養殖産業
    • 養殖動物に影響を及ぼす細菌性疾患の増加
    • 養殖用医薬品に対する政府の好意的な承認
  • 抑制要因
    • 養殖治療薬における抗菌剤耐性の発生
  • 機会
    • 養殖治療薬の進歩とより効果的な養殖治療薬の需要の高まり
    • 養殖治療薬における研究開発を支援するための政府の広範な取り組み
  • 課題
    • 養殖用医薬品の摂取による副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 養殖治療薬市場：製品別

• 絨毛性ゴナドトロピン
• フロルフェニコール
• ホルマリン溶液
• 過酸化水素
• オキシテトラサイクリン
• トリカインメタンスルホン酸塩

第7章 養殖治療薬市場：流通チャネル別

• 電子商取引
• 動物用薬局

第8章 南北アメリカの養殖治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の養殖治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの養殖治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ACD Pharma
• AgriSea
• Aqua Pharma Group
• AquaBounty Technologies, Inc.
• Aquaculture of Texas Inc
• Aquafarm Equipment AS
• Benchmark Holdings PLC
• Biofeyn
• Bionor Laboratories
• Blue Ocean Mariculture
• Ceva Sante Animale
• Elanco Animal Health Incorporated
• Innovasea Systems Inc.
• Kennebec River Biosciences
• Merck & Co., Inc.
• Nutreco NV
• OCEANIUM
• Proteon Pharmaceuticals S.A.
• Syndel Laboratories
• TeOra Pte. Ltd.
• TunaTech GmbH
• Unibio Group
• ViAqua Therapeutics
• VXL DRUGS PRIVATE LIMITED
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. AQUACULTURE THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. AQUACULTURE THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AQUACULTURE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AQUACULTURE THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. POLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. POLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Aquaculture Therapeutics Market was valued at USD 2.51 billion in 2023, expected to reach USD 2.74 billion in 2024, and is projected to grow at a CAGR of 9.13%, to USD 4.64 billion by 2030.

Aquaculture therapeutics encompasses a range of products and treatments designed to enhance the health and yield of aquatic organisms such as fish, mollusks, and crustaceans. This includes pharmaceuticals, vaccines, probiotics, and dietary supplements aimed at preventing disease, improving productivity, and ensuring the health of aquaculture species. The necessity for aquaculture therapeutics arises from the increasing demand for sustainable seafood production, coupled with the challenges of disease management in aquatic farming environments. Applications span across various stages of the aquaculture lifecycle, including breeding, rearing, and harvesting, with end-use domains including fish farms, hatcheries, and aquatic animal health centers.

Market growth is influenced by factors such as increasing global demand for protein-rich diets, technological advancements in aquaculture practices, and the rising incidence of aquatic diseases. Growing awareness of the ecological impact of wild fishing has also fueled investment in more sustainable aquaculture methods. Key opportunities lie in the development of advanced vaccines and bio-based treatment solutions that minimize environmental impact while maximizing fish health and productivity. Effective aquaculture therapeutics not only respond to disease outbreaks but also enhance growth rates and feed efficiency, presenting a compelling avenue for companies looking to innovate.

However, this market faces limitations, including regulatory hurdles and the high cost of treatment development and deployment. The complexity of aquatic ecosystems can make it difficult to implement therapeutics without unintended side effects. Furthermore, the lack of uniform global regulatory standards can complicate market entry and expansion. Research into genetically-modified organisms, precision aquaculture tools like real-time health monitoring, and the development of integrated management systems represents promising areas for innovation. As the market is somewhat fragmented, collaboration with academic institutions, government agencies, and industry stakeholders can provide valuable insights and foster advancements in aquaculture therapeutics. Addressing the need for cost-effective, sustainable, and scalable solutions will be pivotal for capturing growth in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aquaculture Therapeutics Market

The Aquaculture Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing aquaculture industry worldwide
  • Rising bacterial disease affecting the animals cultured in the aquaculture
  • Favourable government approvals for aquaculture drugs
• Market Restraints
  • Occurrence of resistance to antimicrobial agents in aquaculture therapeutics
• Market Opportunities
  • Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs
  • Extensive government initiatives to support R&D in aquaculture therapeutics
• Market Challenges
  • Side effects of consuming aquaculture drugs

Porter's Five Forces: A Strategic Tool for Navigating the Aquaculture Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aquaculture Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aquaculture Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aquaculture Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aquaculture Therapeutics Market

A detailed market share analysis in the Aquaculture Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aquaculture Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aquaculture Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aquaculture Therapeutics Market

A strategic analysis of the Aquaculture Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aquaculture Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ACD Pharma, AgriSea, Aqua Pharma Group, AquaBounty Technologies, Inc., Aquaculture of Texas Inc, Aquafarm Equipment AS, Benchmark Holdings PLC, Biofeyn, Bionor Laboratories, Blue Ocean Mariculture, Ceva Sante Animale, Elanco Animal Health Incorporated, Innovasea Systems Inc., Kennebec River Biosciences, Merck & Co., Inc., Nutreco NV, OCEANIUM, Proteon Pharmaceuticals S.A., Syndel Laboratories, TeOra Pte. Ltd., TunaTech GmbH, Unibio Group, ViAqua Therapeutics, VXL DRUGS PRIVATE LIMITED, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aquaculture Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Chorionic Gonadotropin, Florfenicol, Formalin Solution, Hydrogen Peroxide, Oxytetracycline, and Tricaine Methane Sulfonate.
• Based on Distribution Channel, market is studied across eCommerce and Veterinary Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing aquaculture industry worldwide
    • 5.1.1.2. Rising bacterial disease affecting the animals cultured in the aquaculture
    • 5.1.1.3. Favourable government approvals for aquaculture drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Occurrence of resistance to antimicrobial agents in aquaculture therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs
    • 5.1.3.2. Extensive government initiatives to support R&D in aquaculture therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects of consuming aquaculture drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aquaculture Therapeutics Market, by Product

• 6.1. Introduction
• 6.2. Chorionic Gonadotropin
• 6.3. Florfenicol
• 6.4. Formalin Solution
• 6.5. Hydrogen Peroxide
• 6.6. Oxytetracycline
• 6.7. Tricaine Methane Sulfonate

7. Aquaculture Therapeutics Market, by Distribution Channel

• 7.1. Introduction
• 7.2. eCommerce
• 7.3. Veterinary Pharmacies

8. Americas Aquaculture Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Aquaculture Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Aquaculture Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACD Pharma
• 2. AgriSea
• 3. Aqua Pharma Group
• 4. AquaBounty Technologies, Inc.
• 5. Aquaculture of Texas Inc
• 6. Aquafarm Equipment AS
• 7. Benchmark Holdings PLC
• 8. Biofeyn
• 9. Bionor Laboratories
• 10. Blue Ocean Mariculture
• 11. Ceva Sante Animale
• 12. Elanco Animal Health Incorporated
• 13. Innovasea Systems Inc.
• 14. Kennebec River Biosciences
• 15. Merck & Co., Inc.
• 16. Nutreco NV
• 17. OCEANIUM
• 18. Proteon Pharmaceuticals S.A.
• 19. Syndel Laboratories
• 20. TeOra Pte. Ltd.
• 21. TunaTech GmbH
• 22. Unibio Group
• 23. ViAqua Therapeutics
• 24. VXL DRUGS PRIVATE LIMITED
• 25. Zoetis Inc.